We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Novel Inexpensive, Shelf-Stable, Easy To Use Tests Bring Lab-Level Precision at POC

By LabMedica International staff writers
Posted on 22 May 2024

One of the most critical measurements in healthcare is the blood cell count, which can provide insights into a range of conditions from infections and autoimmune diseases to cancer. More...

Traditionally, collecting a sample for this test involves a blood draw that must be performed at a clinic and analyzed in a centralized clinical laboratory. This requirement can be a significant barrier for homebound individuals or those living in remote areas. Now, researchers have simplified the process to just a finger prick, with blood collected on a paper-dried blood spot card that can be mailed to a lab for analysis, including measurement of white blood cell counts.

Researchers at Tufts University (Medford, MA, USA) are developing methods to perform these tests that significantly reduce costs and increase accessibility. They are utilizing a widely available resource: paper. Their groundbreaking paper-based tests for personal health monitoring do away with the need for costly lab equipment and can be used by anyone, anywhere. These paper analytical devices are inexpensive to produce, can be stored for extended periods, and are easily distributed for use in isolated locations, allowing for critical health data collection at the time and place it's most needed. The team has developed a device known as a patterned dried blood spot card, which features channels and collection zones that precisely measure and dry specific volumes of blood for later analysis. Users simply need to draw blood with a finger prick at home and mail the card to a laboratory, where the amount of DNA unique to white blood cells is measured to determine cell counts.

Additionally, the researchers have developed a paper analytical device to measure lactate, also known as lactic acid, in sweat. Lactate levels can signify oxygen deficiency and serve as a mortality predictor in trauma patients. For athletes or those working in physically demanding environments, lactate also measures muscle fatigue and fitness levels. This device uses bioreactive inks made from silk fibroin—a component of silk fibers—and enzymes that react with lactate to induce a color change. These inks are applied to small paper tabs that adhere to the skin with a common transparent wound dressing film. The tabs change color from yellow to dark red depending on lactate concentration in the sweat, with color changes captured and analyzed using a smartphone camera, achieving accuracy comparable to sophisticated lab equipment.

“People in remote and low-income regions tend to have reduced access to healthcare, which makes it all the more important to come up with cheaper and easier ways for them to monitor indicators of health,” said Charlie Mace, associate professor of chemistry. “This technology is likely to have additional applications in infectious disease such as detecting levels of virus and parasites in the blood and more generally in detecting markers of health and wellness.”

Related Links:
Tufts University


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
C-Reactive Protein Rapid Test
Afinion CRP
New
Hepatitis A Rapid Test
Anti-HAV IgM Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.